Stallion Laboratories Pvt Ltd — Gliclazide Exporter Profile
Indian Pharmaceutical Exporter · #9 for Gliclazide · $2.7M export value · DGFT Verified
Stallion Laboratories Pvt Ltd is the #9 Indian exporter of Gliclazide with $2.7M in export value and 115 verified shipments. Stallion Laboratories Pvt Ltd holds a 1.4% market share in Gliclazide exports across 5 countries.
Stallion Laboratories Pvt Ltd — Gliclazide Export Profile: Buyers & Destinations
Where Does Stallion Laboratories Pvt Ltd Export Gliclazide?
| Country | Value | Shipments | Share |
|---|---|---|---|
| PHILIPPINES | $2.4M | 122 | 93.8% |
| MYANMAR | $86.1K | 5 | 3.3% |
| GAUTEMALA | $24.3K | 2 | 0.9% |
| THAILAND | $20.7K | 2 | 0.8% |
| HONDURAS | $15.4K | 4 | 0.6% |
| MAURITANIA | $13.7K | 2 | 0.5% |
Stallion Laboratories Pvt Ltd exports Gliclazide to 6 countries. The largest destination is PHILIPPINES accounting for 93.8% of Stallion Laboratories Pvt Ltd's Gliclazide shipments, followed by MYANMAR (3.3%) and GAUTEMALA (0.9%). These destinations reflect Stallion Laboratories Pvt Ltd's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Gliclazide from Stallion Laboratories Pvt Ltd?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| TO THE ORDER OF. | PHILIPPINES | $1.1M | 60 |
| TO THE ORDER OF | PHILIPPINES | $448.9K | 23 |
| TO THE ORDER OF, | PHILIPPINES | $298.7K | 17 |
| TO THE ORDER | PHILIPPINES | $187.7K | 13 |
| HAN IDEAL TRADING LTD | MYANMAR | $80.8K | 4 |
| TO THE ORDER, | PHILIPPINES | $40.7K | 2 |
| VITAL PHARMACEUTICAL CO, LTD. | THAILAND | $15.3K | 1 |
| KYAW YADANA TRADING CO. LTD (KYT) | THAILAND | $5.5K | 1 |
| VITAL PHARMA | MYANMAR | $5.3K | 1 |
| CAMEC | MAURITANIA | $4.4K | 1 |
Stallion Laboratories Pvt Ltd supplies Gliclazide to 10 buyers globally. The largest buyer is TO THE ORDER OF. (PHILIPPINES), followed by TO THE ORDER OF (PHILIPPINES) and TO THE ORDER OF, (PHILIPPINES). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Gliclazide Export Value and How Much Does Stallion Laboratories Pvt Ltd Contribute?
India exported $68.5M worth of Gliclazide through 3,830 shipments from 238 suppliers to 109 countries, serving 643 buyers globally. Stallion Laboratories Pvt Ltd contributes $2.7M to this total, accounting for 1.4% of India's Gliclazide exports. Stallion Laboratories Pvt Ltd ships Gliclazide to 6 countries through 10 buyers.
What Is the Average Shipment Value for Stallion Laboratories Pvt Ltd's Gliclazide Exports?
Stallion Laboratories Pvt Ltd's average Gliclazide shipment value is $23.6K per consignment, based on 115 shipments totaling $2.7M. The largest destination is PHILIPPINES (93.8% of Stallion Laboratories Pvt Ltd's Gliclazide exports).
How Does Stallion Laboratories Pvt Ltd Compare to Other Indian Gliclazide Exporters?
Stallion Laboratories Pvt Ltd ranks #9 among 238 Indian Gliclazide exporters with a 1.4% market share. The top 3 exporters are SUN PHARMACEUTICAL INDUSTRIES LIMITED ($15.1M), MICRO LABS LIMITED ($7.6M), IPCA LABORATORIES LIMITED ($7.3M). Stallion Laboratories Pvt Ltd processed 115 shipments to 5 destination countries.
What Gliclazide Formulations Does Stallion Laboratories Pvt Ltd Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| PHARMACEUTICAL DRUGS & MEDICINES GLICLAZIDE 60 MG MODIFIED RELEASE TABLET | $140.0K | 10 |
| PHARMACEUTICAL DRUGS & MEDICINES GLUCLAZZ MR (GLICLAZIDE 60 MG MODIFIED RELEASETABLETS )NOS | $108.4K | 3 |
| GLUCLAZZ MR (GLICLAZIDE MODIFIED RELEASE | $100.0K | 4 |
| GLUCLAZZ MR GLICLAZIDE MODIFIED RELEASE TABLETS 60 MG | $100.0K | 2 |
| PHARMACEUTICAL DRUGS & MEDICINES GLUCLAZZ MR (GLICLAZIDE 60 MG MODIFIED RELEASE TABLET) | $100.0K | 2 |
| PHARMACEUTICAL DRUGS & MEDICINES GLUCLAZZ MR (GLICLAZIDE 60 MG MODIFIED RELEASE TABLETS )TBS | $94.9K | 3 |
| GLUCONEX OD (GLICLAZIDE MODIFIED RELEASE | $81.5K | 8 |
| ZELTINE-MR (GLICLAZIDE MODIFIED RELEASE | $80.5K | 4 |
| PHARMACEUTICAL DRUGS & MEDICINES GLUCONEX OD (GLICLAZIDE 60 MG MODIFIED RELEASE TABLET) | $76.4K | 3 |
| PHARMACEUTICAL DRUGS & MEDICINES ZELTINE-MR (GLICLAZIDE 60 MG MODIFIED RELEASE TABLET) | $71.4K | 2 |
Stallion Laboratories Pvt Ltd exports 81 distinct Gliclazide formulations including tablets, capsules, syrups, and combination drugs. The top formulation is PHARMACEUTICAL DRUGS & MEDICINES GLICLAZIDE 60 MG MODIFIED R with 10 shipments worth $140.0K.
How Does Stallion Laboratories Pvt Ltd Compare to Nearest Gliclazide Exporters?
Exporters ranked immediately above and below #9 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 7 | LUPIN LIMITED | $4.9M | 145 | 8 | $33.6K |
| 8 | MEDREICH LIMITED | $3.6M | 82 | 2 | $43.3K |
| 9 | STALLION LABORATORIES PVT LTD ★ | $2.7M | 115 | 5 | $23.6K |
| 10 | BAL PHARMA LIMITED | $2.6M | 136 | 17 | $18.8K |
| 11 | TORRENT PHARMACEUTICALS LIMITED | $2.5M | 83 | 2 | $30.7K |
Stallion Laboratories Pvt Ltd ranks #9 among 238 Indian Gliclazide exporters. Average shipment value of $23.6K compared to the market average of $287.6K. The closest competitors by value are LUPIN LIMITED and MEDREICH LIMITED.
Which Indian Ports Ship Gliclazide Exports?
| Port | Shipments | % Share |
|---|---|---|
| NHAVA SHEVA SEA (INNSA1) | 439 | 11.5% |
| SAHAR AIR | 375 | 9.8% |
| JNPT/ NHAVA SHEVA SEA | 323 | 8.4% |
| SAHAR AIR CARGO ACC (INBOM4) | 247 | 6.4% |
| DELHI AIR | 229 | 6.0% |
| JNPT | 203 | 5.3% |
| DELHI AIR CARGO ACC (INDEL4) | 165 | 4.3% |
| CMA CGM LOGISTICS PARK ICD | 103 | 2.7% |
Market Intelligence
Latest developments and market context
Detailed market intelligence for Gliclazide — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Gliclazide shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Stallion Laboratories Pvt Ltd matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 137 individual customs records matching Stallion Laboratories Pvt Ltd exporting Gliclazide, covering 81 formulations to 6 countries via 10 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 109+ countries, 643+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Gliclazide Export Data from Stallion Laboratories Pvt Ltd
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Stallion Laboratories Pvt Ltd's Gliclazide exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Stallion Laboratories Pvt Ltd
Company Profile
0 products · $0 total trade · 0 categories
Gliclazide Stats
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Stallion Laboratories Pvt Ltd.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Gliclazide. For current shipment-level data, contact TransData Nexus.